lobbying_activities: 1009069

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1009069	d81ca13d-3311-4f13-804b-e093a60ef2cd	Q3	TAKEDA PHARMACEUTICALS AMERICA, INC.	57954	TAKEDA PHARMACEUTICALS AMERICA INC	2010	third_quarter	MAN	HR 759 Food and Drug Administration Globalization Act of 2009, S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 and General Importation issues, H.R. 2749 Food Safety Safety Enhancement Act, S. 882 The Drug and Device Accountability Act of 2009, Prescription Drug User Fee Act of 2012 preparation, general pedigree and chain drug supply issues, HR 4678 Foreign Manufacturers Legal Accountiblity Act	Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE		510000	0	0	2010-10-20T07:34:33.183000-04:00